Moderna shares fall 6.4%
Moderna shares fell 6.4% after Citi maintained its bearish rating following the release of complete melanoma vaccine data.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.
News Feed
18 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
BUZZ — US STOCKS ON THE MOVE — Walmart, Super Micro, FMC
Workspace search string for individual stock moves: STXBZ The Day Ahead newsletter: The Morning News Call newsletter: (.) The Nasdaq fell to near one-month lows on Thursday, weighed by a worsening selloff in AI-linked stocks on fears rising interest rates could impact artificial-intelligence investments, and fresh data
TRADING DAY — Tech melt
By Jamie McGeever ORLANDO, Florida, Oct 14 (Reuters) — US stocks fell sharply on Wednesday, with the Nasdaq clocking its biggest fall in three months, on surprisingly strong inflation data and deepening worries over the costs involved in financing the AI buildout. The inflation figures put a Fed rate hike later this mo
Immunovant Expects Brepocitinib Launch by End of September
Immunovant CEO Matthew Gline said the company expects to launch brepocitinib by the end of September, pending FDA action. The company also reported enrollment in a phase 3 cutaneous sarcoidosis study and outlined anticipated second-half data readouts.
Stock Market Today: Nasdaq 100 Rebounds From OpenAI Scare, T-Mobile Tumbles 12%
U.S. stocks edged higher by midday Friday, with the Nasdaq rebounding from Thursday’s setback sparked by concerns over OpenAI’s weaker-than-expected revenue, while the wireless carriers were hammered by a Space Exploration Technologies Corp. (NASDAQ: SPCX ) spectrum deal. SpaceX said Thursday it acquired a nationwide 8
Dow Jones futures fall as oil and yields jump
Dow Jones, S&P 500 and Nasdaq futures fell early Thursday as crude oil prices and Treasury yields rose. The article also flagged Samsung, Micron, Taiwan Semiconductor and Sandisk ahead of their updates.
Transcript: Roivant Sciences Q1 2027 Earnings Conference Call
On Thursday, Roivant Sciences (NASDAQ: ROIV ) discussed first-quarter financial results during its earnings call. The full transcript is provided below. This content is powered APIs. For comprehensive financial data and transcripts, visit The full earnings call is available at Summary Roivant Sciences reported a quiet
Moderna slips after Citi downgrades MRNA to sell
Moderna shares fell 6.2% to $190.89 premarket after Citigroup downgraded MRNA to "sell" from "neutral"; Citi raised its price target to $80 from $60.
AMD Hits $1 Trillion, Muse Spooks Subscription Stocks: This Week on Wall Street
Wall Street closed the week riding a semiconductor rebound that pushed the AI infrastructure trade back into favor, even as a spike in Treasury yields tested the rally’s staying power. Advanced Micro Devices Inc. (NASDAQ: AMD ) supplied the week’s biggest milestone. Shares surged as much as 10% on Monday, pushing the c
Immunovant Q1 2027 Earnings Call: Complete Transcript
On Thursday, Immunovant (NASDAQ: IMVT ) discussed first-quarter financial results during its earnings call. The full transcript is provided below. This transcript is brought to you APIs. For real-time access to our entire catalog, please visit for a consultation. View the webcast at Summary Immunovant reported a quiet
Novavax shares rise after FDA authorization and guidance upgrade
Novavax shares are trading higher Tuesday after U.S. FDA emergency use authorization for its updated 2026-2027 Nuvaxovid vaccine and an earlier Q2 update that raised full-year revenue guidance.
Nasdaq 100 falls as hot PCE inflation lifts rate-hike bets
U.S. stocks drifted lower midday Wednesday after July PCE inflation met monthly forecasts but ran hotter than expected annually, while second-quarter GDP growth was confirmed at an annualized 1.5%.
Moderna, Cadeler, Marvell among stocks rising on Tuesday
Moderna, Cadeler and Marvell Technology trade higher Tuesday alongside other names after analyst upgrades, a higher FY26 sales guide and other company-specific developments.
Ross Stores raises 2026 earnings guidance after Q2 double beat
Ross Stores reported second-quarter revenue of $6.27 billion and earnings of $2.66 per share, both above estimates, and lifted 2026 earnings guidance to $8.61-$8.77 per share.
Webull reports Q2 revenue growth, EPS beat as users rise
Webull Corp reported second-quarter revenue of $198.83 million, up 51% year over year and above the $181.26 million estimate, while adjusted EPS of 5 cents beat expectations of 3 cents.
Lowe’s shares rise after mixed Q2, guidance cut below estimates
Lowe’s Companies shares rise after the retailer reported mixed second-quarter 2026 results, with adjusted EPS of $4.40 beating the $4.22 estimate while net sales of $25.96 billion missed $26.16 billion and full-year outlook narrowed below Wall Street estimates.
CoreWeave falls as yields, oil and geopolitical tensions weigh
CoreWeave Inc. (NASDAQ: CRWV) trades lower as a broad rotation hits leveraged high-growth technology shares, with higher Treasury yields, rising crude oil and geopolitical tensions cited.
Target posts upbeat Q2 earnings, raises FY2026 guidance
Target reported Q2 earnings of $2.46 per share versus the $2.33 analyst consensus estimate and sales of $26.539 billion versus $26.141 billion, then raised FY2026 adjusted EPS guidance and sales forecast.